SCHEMBL9481109

SCHEMBL9481109

CON=C(C(=O)O)c1nc(NC(=O)OC(C)(C)C)cs1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ PI4KB Q9UBF8 1/20 0.33
▸ LEF1 Q9UJU2 1/20 0.32
▸ ATR Q13535 1/20 0.32
▸ GSK3B P49841 1/20 0.32
▸ DYRK1A Q13627 1/20 0.32
▸ LCK P06239 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ CA1 P00915 1/20 0.32
▸ CA2 P00918 1/20 0.32
▸ METAP1 P53582 1/20 0.31
▸ PSMB8 P28062 1/20 0.31
▸ SIRT1 Q96EB6 1/20 0.31
▸ SREBF2 Q12772 1/20 0.31
▸ SCN9A Q15858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9481102 1.00 GAA (0.41) GAALMNAMAPTPI4KBLEF1
SCHEMBL9482908 1.00 GAA (0.41) GAALMNAMAPTPI4KBLEF1
SCHEMBL10846586 0.87 ABCB1 (0.32) GAALMNAMAPTPI4KBLEF1
SCHEMBL10846580 0.87 ABCB1 (0.32) GAALMNAMAPTPI4KBLEF1
SCHEMBL9481637 0.82 GSK3B (0.37) GAAPI4KBGSK3BDYRK1ALCK
SCHEMBL26678642 0.82 PI4KB (0.38) GAAPI4KBATRGSK3BDYRK1A
SCHEMBL6051342 0.78 LMNA (0.61) GAALMNAMAPTPI4KBLCK
SCHEMBL6051333 0.78 LMNA (0.61) GAALMNAMAPTPI4KBLCK
SCHEMBL31264442 0.78 LMNA (0.61) GAALMNAMAPTPI4KBLCK
SCHEMBL21705628 0.73 LCK (0.41) PI4KBATRGSK3BDYRK1ALCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5252731-A Antibiotics FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-10-12 — — US disclosed
US-5110921-A Bactericides FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-05-05 — — US disclosed
US-4960889-A CEPHALOSPORIN INTERMEDIATES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-10-02 — — US disclosed
US-4731443-A 7-acylamino-3-vinylcephalosporanic acid derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-03-15 — — US disclosed
EP-0244637-A1 Starting compounds for 7-acylamino-3-vinylcephalosporanic acid derivatives and processes for their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-11-11 — — EP disclosed
US-4585860-A ANTIBIOTICS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-04-29 — — US disclosed
US-4487927-A BACTERICIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-12-11 — — US disclosed
EP-0123024-A2 7-Acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them; their starting compounds and their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-31 — — EP disclosed
US-4423213-A ANTIBIOTIC FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-12-27 — — US disclosed
US-4409214-A Including cefixime; antibiotics FUJISAWA PHARMACEUTICAL, CO., LTD. (JP) 1983-10-11 — — US disclosed
EP-0030630-A2 7-Acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them; their starting compounds and their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-06-24 — — EP disclosed
Send feedback